EUVIMEDEUVIMED entdecken
Crossref

Immunopharmacologsical and structural insights into Rift Valley fever virus envelope glycoproteins: an immunoinformatics approach to multi-epitope vaccine design

Tariq Aziz, Mohammed A Alshehri, Maha A Aljumaa, Hanan Abdulrahman Sagini, Ghulam Nabi

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-08 · 399 (11) · 18139-18155

DOI: 10.1007/s00210-026-05493-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 06.06.2026. Verfasst von Tariq Aziz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, University of Tabuk, 71491, Tabuk, Saudi Arabia. tariqckd@ut.edu.sa. Hauptthemen laut MEDLINE: Rift Valley fever virus, Viral Envelope Proteins, Viral Vaccines, Epitopes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Princess Nourah Bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rift Valley fever (RVF) is a clinically zoonotic pathogen associated with severe systemic and neurological complications, for which no approved vaccine is currently available. This study aimed to design a novel chimeric multi-epitope vaccine candidate targeting the RVFV Envelope polyprotein (Gn and Gc) via an integrative immunoinformatic and structural modeling approach, targeting viral envelope glycoproteins which play a crucial role in host cell entry and immune recognition. The epitopes used in the vaccine assembly were selected on the basis of antigenicity, allergenicity, and toxicity, then linked to the RS09 adjuvant and optimized using linkers. The vaccine's 3D model was built using AlphaFold 3, and its potential to bind to the human TLR4 receptor (PDB ID: 4G8A) was investigated using ClusPro 2.0 docking. Population coverage and immune simulation were conducted using IEDB and the C-ImmSim server, respectively. The vaccine is highly antigenic, soluble, stable, and has a global population coverage of more than 90%. In addition, the vaccine was found to be effective as indicated by a high binding energy and good complementarity to the complex formed by the TLR4 receptor. This study demonstrates that a highly effective and safe vaccine candidate for global RVF prevention is feasible and should be considered for development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rift Valley fever virusViral Envelope ProteinsViral VaccinesEpitopesRift Valley FeverImmunoinformaticsHumansMolecular Docking SimulationToll-Like Receptor 4GlycoproteinsProtein Subunit VaccinesDrug Design

Stichwörter der Autor:innen

Envelope glycoproteinsImmunoinformaticsImmunopharmacologyMulti-epitope vaccineRift Valley fever virusStructural modeling

Substanzen

Viral Envelope ProteinsViral VaccinesEpitopesToll-Like Receptor 4GlycoproteinsProtein Subunit VaccinesTLR4 protein, human

Autor:innen und Institutionen

  • Department of Biology, College of Science, University of Tabuk, 71491, Tabuk, Saudi Arabia. tariqckd@ut.edu.sa.
  • Department of Biology, College of Science, University of Tabuk, 71491, Tabuk, Saudi Arabia.
  • Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia.
  • Department of Biological Sciences, College of Sciences, University of Jeddah, 21959, Jeddah, Saudi Arabia.
  • Department of Zoology, University of Swat, Swat, 19200, Khyber Pakhtunkhwa, Pakistan. ghulamnabiqau@gmail.com.

Förderung

  • Princess Nourah Bint Abdulrahman University

Zitieren

APA

Aziz, T., Alshehri, M. A., Aljumaa, M. A., Sagini, H. A., & Nabi, G. (2026). Immunopharmacologsical and structural insights into Rift Valley fever virus envelope glycoproteins: an immunoinformatics approach to multi-epitope vaccine design. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(11), 18139-18155. https://doi.org/10.1007/s00210-026-05493-5

Vancouver

Aziz T, Alshehri MA, Aljumaa MA, Sagini HA, Nabi G. Immunopharmacologsical and structural insights into Rift Valley fever virus envelope glycoproteins: an immunoinformatics approach to multi-epitope vaccine design. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(11):18139-18155. doi:10.1007/s00210-026-05493-5

BibTeX
@article{Aziz2026,
  author = {Aziz, Tariq and Alshehri, Mohammed A and Aljumaa, Maha A and Sagini, Hanan Abdulrahman and Nabi, Ghulam},
  title = {Immunopharmacologsical and structural insights into Rift Valley fever virus envelope glycoproteins: an immunoinformatics approach to multi-epitope vaccine design},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {11},
  pages = {18139--18155},
  doi = {10.1007/s00210-026-05493-5}
}
Kostenlos starten →